Predictions
Capital One Financial
Start price
Target price
Perf. (%)
€106.00
04.12.23
04.12.23
€115.14
04.12.24
04.12.24
20.44%
06.09.24
06.09.24
Broadcom Ltd.
Start price
Target price
Perf. (%)
€857.10
04.12.23
04.12.23
€1,013.2
04.12.24
04.12.24
-83.89%
06.09.24
06.09.24
Broadcom Ltd.
Start price
Target price
Perf. (%)
€857.10
04.12.23
04.12.23
€1,013.2
04.12.24
04.12.24
-83.89%
06.09.24
06.09.24
Broadcom Ltd.
Start price
Target price
Perf. (%)
€857.10
04.12.23
04.12.23
€1,013.2
04.12.24
04.12.24
-83.89%
06.09.24
06.09.24
Mersana Therapeutics
Start price
Target price
Perf. (%)
€1.71
04.12.23
04.12.23
€4.61
04.12.24
04.12.24
-24.94%
05.09.24
05.09.24
Hamborner REIT AG
Start price
Target price
Perf. (%)
€6.62
04.12.23
04.12.23
€9.00
04.12.24
04.12.24
3.93%
05.04.24
05.04.24
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Bluebird Bio Inc.
Start price
Target price
Perf. (%)
€4.00
02.12.23
02.12.23
€5.00
31.10.25
31.10.25
-30.50%
10.12.23
10.12.23
Could be very worthwhile Investment >20% year
Brainstorm Cell
Start price
Target price
Perf. (%)
€0.25
02.12.23
02.12.23
€0.40
30.11.25
30.11.25
-29.60%
10.12.23
10.12.23
Could be very worthwhile Investment >20% year
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€30.60
02.12.23
02.12.23
€60.00
28.02.26
28.02.26
7.19%
10.12.23
10.12.23
Could be very worthwhile Investment >20% year
Moderna Inc.
Start price
Target price
Perf. (%)
€73.21
02.12.23
02.12.23
€74.00
02.12.24
02.12.24
15.01%
14.12.23
14.12.23
Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
Heineken N.V.
Start price
Target price
Perf. (%)
€83.42
02.12.23
02.12.23
-
02.12.24
02.12.24
-1.37%
06.09.24
06.09.24
Could be worthwhile Investment >10% per year
Nike Inc. B
Start price
Target price
Perf. (%)
€104.48
02.12.23
02.12.23
€105.00
02.12.24
02.12.24
4.61%
11.12.23
11.12.23
Standard Investments for future growth
Valuable balance sheet
Growths faster than the competition
Medium risks for its business
Nike Inc. B
Start price
Target price
Perf. (%)
€104.48
02.12.23
02.12.23
€105.00
02.12.24
02.12.24
4.61%
11.12.23
11.12.23
Standard Investments for future growth
Valuable balance sheet
Growths faster than the competition
Medium risks for its business
MicroVision Inc
Start price
Target price
Perf. (%)
€2.44
02.12.23
02.12.23
€2.00
02.12.24
02.12.24
-1.29%
05.12.23
05.12.23
Fair valuation
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Avenue Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.18
02.12.23
02.12.23
€0.35
02.12.24
02.12.24
-28.97%
17.02.24
17.02.24
Could be very worthwhile Investment >20% year
BYD Co. Ltd
Start price
Target price
Perf. (%)
€24.35
02.12.23
02.12.23
€29.00
02.12.24
02.12.24
11.01%
06.09.24
06.09.24
Revenue growth >5% per year expected
ROE higher than 10% per year
Very Future proof/growth oriented business model
Very positive Cash Flow expected